Targeting STAT3 Enzyme for Cancer Treatment

被引:0
|
作者
Arun, Sowmiya [1 ]
Patel, Praveen Kumar [1 ]
Lakshmanan, Kaviarasan [2 ]
Rajangopal, Kalirajan [1 ]
Swaminathan, Gomathi [1 ]
Byran, Gowramma [1 ]
机构
[1] JSS Acad Higher Educ & Res, Dept Pharmaceut Chem, JSS Coll Pharm, Nilgiris 643001, Tamil Nadu, India
[2] Satyabhama Inst Sci & Technol, Sch Pharm, Dept Pharmaceut Chem, Chennai, Tamil Nadu, India
关键词
STAT3; inhibitors; SH-2; domain; proliferation; phosphorylation; hematological malignancies; tyrosine residue; NF-KAPPA-B; SIGNAL TRANSDUCER; TRANSCRIPTION; 3; KEY REGULATOR; EXPRESSION; ACTIVATOR; COMMUNICATION; SUPPRESSOR; APOPTOSIS; REVEALS;
D O I
10.2174/0113895575254012231024062619
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A category of cytoplasmic transcription factors called STATs mediates intracellular signaling, which is frequently generated at receptors on cell surfaces and subsequently sent to the nucleus. STAT3 is a member of a responsible for a variety of human tumor forms, including lymphomas, hematological malignancies, leukemias, multiple myeloma and several solid tumor types. Numerous investigations have demonstrated constitutive STAT3 activation lead to cancer development such as breast, head and neck, lung, colorectal, ovarian, gastric, hepatocellular, and prostate cancers. It's possible to get a hold of the book here. Tumor cells undergo apoptosis when STAT3 activation is suppressed. This review highlights the STAT3 activation and inhibition which can be used for further studies.
引用
收藏
页码:1252 / 1261
页数:10
相关论文
共 50 条
  • [41] Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
    Li, Dan
    Wang, Gangcheng
    Jin, Guoguo
    Yao, Ke
    Zhao, Zhenjiang
    Bie, Liangyu
    Guo, Yongjun
    Li, Ning
    Deng, Wenying
    Chen, Xiaobin
    Chen, Beibei
    Liu, Yuanyuan
    Luo, Suxia
    Guo, Zhiping
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (01) : 630 - 640
  • [42] MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis
    Yang, Yan
    Ding, Lili
    Hu, Qun
    Xia, Jia
    Sun, Junjie
    Wang, Xudong
    Xiong, Hua
    Gurbani, Deepak
    Li, Lianbo
    Liu, Yan
    Liu, Aiguo
    MOLECULAR CANCER, 2017, 16
  • [43] Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells
    Okamoto, W.
    Okamoto, I.
    Arao, T.
    Yanagihara, K.
    Nishio, K.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2011, 105 (03) : 407 - 412
  • [44] Probing the Depths of Molecular Complexity: STAT3 as a Key Architect in Colorectal Cancer Pathogenesis
    Suleman, Muhammad
    Khan, Safir Ullah
    Ali, Shahid
    Alghamdi, Abdullah
    Alissa, Mohammed
    Mushtaq, Rayan Y.
    Crovella, Sergio
    CURRENT GENE THERAPY, 2024,
  • [45] STATs in cancer inflammation and immunity: a leading role for STAT3
    Yu, Hua
    Pardoll, Drew
    Jove, Richard
    NATURE REVIEWS CANCER, 2009, 9 (11) : 798 - 809
  • [46] Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis
    Chen, Qi
    Lv, Jianjun
    Yang, Wenwen
    Xu, Baoping
    Wang, Zheng
    Yu, Zihao
    Wu, Jiawei
    Yang, Yang
    Han, Yuehu
    THERANOSTICS, 2019, 9 (22): : 6424 - 6442
  • [47] Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
    Dong, Yushan
    Chen, Jingyu
    Chen, Yuhan
    Liu, Songjiang
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [48] Importance of STAT3 signalling in cancer, metastasis and therapeutic interventions
    El-Tanani, Mohamed
    Al Khatib, Arwa Omar
    Aladwan, Safwan Mahmoud
    Abuelhana, Ahmed
    McCarron, Paul A.
    Tambuwala, Murtaza M.
    CELLULAR SIGNALLING, 2022, 92
  • [49] Overexpression of STAT3 Potentiates Growth, Survival, and Radioresistance of Non-Small-Cell Lung Cancer (NSCLC) cells
    Yin, Zhen-Jie
    Jin, Fa-Guang
    Liu, Tong-Gang
    Fu, En-Qing
    Xie, Yong-Hong
    Sun, Rui-Lin
    JOURNAL OF SURGICAL RESEARCH, 2011, 171 (02) : 675 - 683
  • [50] Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
    Chen, Huang
    Bian, Aiwu
    Yang, Lian-fang
    Yin, Xuan
    Wang, Jie
    Ti, Chaowen
    Miao, Ying
    Peng, Shihong
    Xu, Shifen
    Liu, Mingyao
    Qiu, Wen-Wei
    Yi, Zhengfang
    ONCOGENE, 2021, 40 (08) : 1440 - 1457